BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 36994809)

  • 1. Computational analysis of a microRNA signature for poor prognosis suggests a microRNA-controlled stemness pathway in paediatric acute leukaemia.
    Erkeland SJ
    Br J Haematol; 2023 Jul; 202(1):11-12. PubMed ID: 36994809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A miRNA signature related to stemness identifies high-risk patients in paediatric acute myeloid leukaemia.
    Esperanza-Cebollada E; Gómez-González S; Perez-Jaume S; Vega-García N; Vicente-Garcés C; Richarte-Franqués M; Rives S; Català A; Torrebadell M; Camós M
    Br J Haematol; 2023 Jul; 202(1):96-110. PubMed ID: 36951259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic & prognostic role of microRNAs in paediatric acute myeloid leukaemia.
    Kumar S; Bakhshi S
    Indian J Med Res; 2016 Dec; 144(6):807-814. PubMed ID: 28474617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and validation of GMI signature based random survival forest prognosis model to predict clinical outcome in acute myeloid leukemia.
    Shi M; Xu G
    BMC Med Genomics; 2019 Jun; 12(1):90. PubMed ID: 31242922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A 4-microRNA signature for survival prognosis in pediatric and adolescent acute myeloid leukemia.
    Zhu R; Lin W; Zhao W; Fan F; Tang L; Hu Y
    J Cell Biochem; 2019 Mar; 120(3):3958-3968. PubMed ID: 30242879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypermethylation and down-regulation of DLEU2 in paediatric acute myeloid leukaemia independent of embedded tumour suppressor miR-15a/16-1.
    Morenos L; Chatterton Z; Ng JL; Halemba MS; Parkinson-Bates M; Mechinaud F; Elwood N; Saffery R; Wong NC
    Mol Cancer; 2014 May; 13():123. PubMed ID: 24885794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 3-miRNA signature predicts prognosis of pediatric and adolescent cytogenetically normal acute myeloid leukemia.
    Zhu R; Zhao W; Fan F; Tang L; Liu J; Luo T; Deng J; Hu Y
    Oncotarget; 2017 Jun; 8(24):38902-38913. PubMed ID: 28473658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treating second-relapsed/refractory first-relapsed childhood acute myeloid leukaemia: Successful salvage rather than palliation?
    Merli P
    Br J Haematol; 2022 Jun; 197(6):651-652. PubMed ID: 35435248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High CX3CR1 expression predicts poor prognosis in paediatric acute myeloid leukaemia undergoing hyperleukocytosis.
    Mei N; Su H; Gong S; Du H; Zhang X; Wang L; Wang H
    Int J Lab Hematol; 2023 Feb; 45(1):53-63. PubMed ID: 36064206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The lincRNA HOTAIRM1, located in the HOXA genomic region, is expressed in acute myeloid leukemia, impacts prognosis in patients in the intermediate-risk cytogenetic category, and is associated with a distinctive microRNA signature.
    Díaz-Beyá M; Brunet S; Nomdedéu J; Pratcorona M; Cordeiro A; Gallardo D; Escoda L; Tormo M; Heras I; Ribera JM; Duarte R; de Llano MP; Bargay J; Sampol A; Nomdedeu M; Risueño RM; Hoyos M; Sierra J; Monzo M; Navarro A; Esteve J;
    Oncotarget; 2015 Oct; 6(31):31613-27. PubMed ID: 26436590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A three-miRNA-based expression signature at diagnosis can predict occurrence of relapse in children with t(8;21) RUNX1-RUNX1T1 acute myeloid leukaemia.
    Zampini M; Bisio V; Leszl A; Putti MC; Menna G; Rizzari C; Pession A; Locatelli F; Basso G; Tregnago C; Pigazzi M
    Br J Haematol; 2018 Oct; 183(2):298-301. PubMed ID: 28961307
    [No Abstract]   [Full Text] [Related]  

  • 12. miRNA-mRNA Profiling Reveals Prognostic Impact of
    Gadewal N; Kumar R; Aher S; Gardane A; Gaur T; Varma AK; Khattry N; Hasan SK
    Oncol Res; 2020 May; 28(3):321-330. PubMed ID: 32059753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysregulation of miRNA expression and their prognostic significance in paediatric cytogenetically normal acute myeloid leukaemia.
    Gaur V; Chaudhary S; Tyagi A; Agarwal S; Sharawat SK; Sarkar S; Singh H; Bakhshi S; Sharma P; Kumar S
    Br J Haematol; 2020 Mar; 188(6):e90-e94. PubMed ID: 32077100
    [No Abstract]   [Full Text] [Related]  

  • 14. MicroRNA biomarker identification for pediatric acute myeloid leukemia based on a novel bioinformatics model.
    Yan W; Xu L; Sun Z; Lin Y; Zhang W; Chen J; Hu S; Shen B
    Oncotarget; 2015 Sep; 6(28):26424-36. PubMed ID: 26317787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low frequency of MLL-partial tandem duplications in paediatric acute myeloid leukaemia using MLPA as a novel DNA screenings technique.
    Balgobind BV; Hollink IH; Reinhardt D; van Wering ER; de Graaf SS; Baruchel A; Stary J; Beverloo HB; de Greef GE; Pieters R; Zwaan CM; van den Heuvel-Eibrink MM
    Eur J Cancer; 2010 Jul; 46(10):1892-9. PubMed ID: 20233657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole-exome sequencing reveals the spectrum of gene mutations and the clonal evolution patterns in paediatric acute myeloid leukaemia.
    Shiba N; Yoshida K; Shiraishi Y; Okuno Y; Yamato G; Hara Y; Nagata Y; Chiba K; Tanaka H; Terui K; Kato M; Park MJ; Ohki K; Shimada A; Takita J; Tomizawa D; Kudo K; Arakawa H; Adachi S; Taga T; Tawa A; Ito E; Horibe K; Sanada M; Miyano S; Ogawa S; Hayashi Y
    Br J Haematol; 2016 Nov; 175(3):476-489. PubMed ID: 27470916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute myeloid leukemia with translocation (8;16)(p11;p13) and MYST3-CREBBP rearrangement harbors a distinctive microRNA signature targeting RET proto-oncogene.
    Díaz-Beyá M; Navarro A; Ferrer G; Díaz T; Gel B; Camós M; Pratcorona M; Torrebadell M; Rozman M; Colomer D; Monzo M; Esteve J
    Leukemia; 2013 Mar; 27(3):595-603. PubMed ID: 23022987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 5-microRNA signature derived from core binding factor-AML is predictive in adult and childhood AML.
    Gabra MM; Chow JT; Kim T; Son MH; Arruda A; Woolley JF; Zhang Z; Minden MD; Salmena L
    Leuk Res; 2022 Dec; 123():106968. PubMed ID: 36242827
    [No Abstract]   [Full Text] [Related]  

  • 19. Human circulating small non-coding RNA signature as a non-invasive biomarker in clinical diagnosis of acute myeloid leukaemia.
    Xia L; Guo H; Wu X; Xu Y; Zhao P; Yan B; Zeng Y; He Y; Chen D; Gale RP; Zhang Y; Zhang X
    Theranostics; 2023; 13(4):1289-1301. PubMed ID: 36923527
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical and biological features of paediatric acute myeloid leukaemia (AML) with primary induction failure in the Japanese Paediatric Leukaemia/Lymphoma Study Group AML-05 study.
    Miyamura T; Moritake H; Nakayama H; Tanaka S; Tomizawa D; Shiba N; Saito AM; Tawa A; Shimada A; Iwamoto S; Hayashi Y; Koike T; Horibe K; Manabe A; Mizutani S; Taga T; Adachi S
    Br J Haematol; 2019 Apr; 185(2):284-288. PubMed ID: 30784060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.